Clinical Trial Update: A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation [Phase 1]

View source ↗

Summary

Phase Ib clinical trial update for JMKX001899 in combination with other therapies for advanced non-small cell lung cancer harboring KRAS G12C mutation; recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JMKX001899

Snippet

Sponsor: Jemincare | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 | Status: RECRUITING